Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Intravascular Ultrasound for Hepatocellular Carcinoma Staging
This study is currently recruiting participants.
Verified by University Hospital, Geneva, May 2007
Sponsored by: University Hospital, Geneva
Information provided by: University Hospital, Geneva
ClinicalTrials.gov Identifier: NCT00474734
  Purpose

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.

As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.


Condition Intervention
Hepatocellular Carcinoma
Device: Intravascular ultrasound of the liver

MedlinePlus related topics: Cancer Liver Transplantation Ultrasound
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Longitudinal, Defined Population, Prospective Study
Official Title: Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study

Further study details as provided by University Hospital, Geneva:

Study Start Date: May 2007
Estimated Study Completion Date: September 2007
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hepatocellular carcinoma nodules
  • patient on liver transplantation waiting list
  • written informed consent

Exclusion Criteria:

  • thrombosis of hepatic veins or vena cava
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00474734

Contacts
Contact: Antoine Hadengue, Prof. +41 22 37 29 340 antoine.hadengue@hcuge.ch

Locations
Switzerland
University Hospital Geneva Recruiting
Geneva, Switzerland
Contact: Andrea De Gottardi, MD PhD     +41 22 37 29 256     andrea.degottardi@hcuge.ch    
Sponsors and Collaborators
University Hospital, Geneva
Investigators
Study Chair: Antoine Hadengue, Prof. University Hospital, Geneva
  More Information

Study ID Numbers: 07-063
Study First Received: May 15, 2007
Last Updated: May 16, 2007
ClinicalTrials.gov Identifier: NCT00474734  
Health Authority: Switzerland: Swissmedic

Keywords provided by University Hospital, Geneva:
hepatocellular carcinoma
liver transplantation
staging
intravascular ultrasound

Study placed in the following topic categories:
Liver Neoplasms
Liver Diseases
Digestive System Diseases
Digestive System Neoplasms
Carcinoma, Hepatocellular
Liver neoplasms
Gastrointestinal Neoplasms
Adenocarcinoma
Hepatocellular carcinoma
Neoplasms, Glandular and Epithelial
Carcinoma

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on January 16, 2009